{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:40:00Z","timestamp":1789998000377,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["P30CA014236"],"award-info":[{"award-number":["P30CA014236"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Duke Institute for Healthcare Innovation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s11606-020-06124-2","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T19:03:41Z","timestamp":1598987021000},"page":"92-99","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Implementation and Impact of a Risk-Stratified Prostate Cancer Screening Algorithm as a Clinical Decision Support Tool in a Primary Care Network"],"prefix":"10.1007","volume":"36","author":[{"given":"Anand","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Polascik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Hyslop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia M.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ferrandino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn M.","family":"Preminger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan T.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Robert","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine J.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ragsdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coleman","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon K.","family":"Check","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Aminsharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Schulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Sze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrat","family":"Tsivian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kae Jack","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Patierno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Oeffinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6938-698X","authenticated-orcid":false,"given":"Kevin","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"key":"6124_CR1","unstructured":"Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER cancer statistics review, 1975-2016. National Cancer Institute. Bethesda, April 2019. https:\/\/seer.cancer.gov\/csr\/1975_2016\/."},{"key":"6124_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A: Cancer statistics, 2019. CA Cancer J Clin 69:7-34, 2019","journal-title":"CA Cancer J Clin"},{"key":"6124_CR3","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1016\/S0140-6736(14)60525-0","volume":"384","author":"FH Schroder","year":"2014","unstructured":"Schroder FH, Hugosson J, Roobol MJ, et al: Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 384:2027-35, 2014","journal-title":"Lancet"},{"key":"6124_CR4","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1001\/jama.2018.3712","volume":"319","author":"JJ Fenton","year":"2018","unstructured":"Fenton JJ, Weyrich MS, Durbin S, et al: Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 319:1914-1931, 2018","journal-title":"JAMA"},{"key":"6124_CR5","first-page":"5875","volume":"18","author":"LG Gomella","year":"2011","unstructured":"Gomella LG, Liu XS, Trabulsi EJ, et al: Screening for prostate cancer: the current evidence and guidelines controversy. Can J Urol 18:5875-83, 2011","journal-title":"Can J Urol"},{"key":"6124_CR6","doi-asserted-by":"publisher","first-page":"770","DOI":"10.7326\/M19-1072","volume":"170","author":"RB Burns","year":"2019","unstructured":"Burns RB, Olumi AF, Owens DK, et al: Would You Recommend Prostate-Specific Antigen Screening for This Patient?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Ann Intern Med 170:770-778, 2019","journal-title":"Ann Intern Med"},{"key":"6124_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/jnci\/djq099","volume":"102","author":"HG Welch","year":"2010","unstructured":"Welch HG, Black WC: Overdiagnosis in cancer. J Natl Cancer Inst 102:605-13, 2010","journal-title":"J Natl Cancer Inst"},{"key":"6124_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","volume":"157","author":"VA Moyer","year":"2012","unstructured":"Moyer VA, Force USPST: Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 157:120-34, 2012","journal-title":"Ann Intern Med"},{"key":"6124_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3322\/caac.21212","volume":"64","author":"RA Smith","year":"2014","unstructured":"Smith RA, Manassaram-Baptiste D, Brooks D, et al: Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 64:30-51, 2014","journal-title":"CA Cancer J Clin"},{"key":"6124_CR10","doi-asserted-by":"publisher","first-page":"686","DOI":"10.6004\/jnccn.2014.0072","volume":"12","author":"JL Mohler","year":"2014","unstructured":"Mohler JL, Kantoff PW, Armstrong AJ, et al: Prostate cancer, version 2.2014. J Natl Compr Cancer Netw 12:686-718, 2014","journal-title":"J Natl Compr Cancer Netw"},{"key":"6124_CR11","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1001\/jama.2015.14905","volume":"314","author":"A Jemal","year":"2015","unstructured":"Jemal A, Fedewa SA, Ma J, et al: Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations. JAMA 314:2054-61, 2015","journal-title":"JAMA"},{"key":"6124_CR12","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.juro.2017.09.103","volume":"199","author":"KA Houston","year":"2018","unstructured":"Houston KA, King J, Li J, et al: Trends in Prostate Cancer Incidence Rates and Prevalence of Prostate Specific Antigen Screening by Socioeconomic Status and Regions in the United States, 2004 to 2013. J Urol 199:676-682, 2018","journal-title":"J Urol"},{"key":"6124_CR13","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1056\/NEJMsb1616281","volume":"376","author":"PF Pinsky","year":"2017","unstructured":"Pinsky PF, Prorok PC, Kramer BS: Prostate Cancer Screening - A Perspective on the Current State of the Evidence. N Engl J Med 376:1285-1289, 2017","journal-title":"N Engl J Med"},{"key":"6124_CR14","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/cncr.30474","volume":"123","author":"PF Pinsky","year":"2017","unstructured":"Pinsky PF, Prorok PC, Yu K, et al: Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years. Cancer 123:592-599, 2017","journal-title":"Cancer"},{"key":"6124_CR15","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2018.3710","volume":"319","author":"USPST Force","year":"2018","unstructured":"Force USPST, Grossman DC, Curry SJ, et al: Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 319:1901-1913, 2018","journal-title":"JAMA"},{"key":"6124_CR16","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","volume":"360","author":"GL Andriole","year":"2009","unstructured":"Andriole GL, Crawford ED, Grubb RL, 3rd, et al: Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360:1310-9, 2009","journal-title":"N Engl J Med"},{"key":"6124_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3322\/caac.21555","volume":"69","author":"CE DeSantis","year":"2019","unstructured":"DeSantis CE, Miller KD, Goding Sauer A, et al: Cancer statistics for African Americans, 2019. CA Cancer J Clin 69:211-233, 2019","journal-title":"CA Cancer J Clin"},{"key":"6124_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3322\/caac.21446","volume":"68","author":"RA Smith","year":"2018","unstructured":"Smith RA, Andrews KS, Brooks D, et al: Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 68:297-316, 2018","journal-title":"CA Cancer J Clin"},{"key":"6124_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.6004\/jnccn.2019.0023","volume":"17","author":"JL Mohler","year":"2019","unstructured":"Mohler JL, Antonarakis ES, Armstrong AJ, et al: Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw 17:479-505, 2019","journal-title":"J Natl Compr Cancer Netw"},{"key":"6124_CR20","doi-asserted-by":"publisher","first-page":"c4521","DOI":"10.1136\/bmj.c4521","volume":"341","author":"AJ Vickers","year":"2010","unstructured":"Vickers AJ, Cronin AM, Bjork T, et al: Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study. BMJ 341:c4521, 2010","journal-title":"BMJ"},{"key":"6124_CR21","doi-asserted-by":"publisher","first-page":"f2023","DOI":"10.1136\/bmj.f2023","volume":"346","author":"AJ Vickers","year":"2013","unstructured":"Vickers AJ, Ulmert D, Sjoberg DD, et al: Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study. BMJ 346:f2023, 2013","journal-title":"BMJ"},{"key":"6124_CR22","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1200\/JCO.2016.66.7527","volume":"34","author":"MA Preston","year":"2016","unstructured":"Preston MA, Batista JL, Wilson KM, et al: Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer. J Clin Oncol 34:2705-11, 2016","journal-title":"J Clin Oncol"},{"key":"6124_CR23","doi-asserted-by":"publisher","first-page":"502.e1","DOI":"10.1016\/j.urolonc.2018.07.016","volume":"36","author":"A Aminsharifi","year":"2018","unstructured":"Aminsharifi A, Schulman A, Anderson J, et al: Primary care perspective and implementation of a multidisciplinary, institutional prostate cancer screening algorithm embedded in the electronic health record. Urol Oncol 36:502.e1-502.e6, 2018","journal-title":"Urol Oncol"},{"key":"6124_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa1113162","volume":"367","author":"TJ Wilt","year":"2012","unstructured":"Wilt TJ, Brawer MK, Jones KM, et al: Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 367:203-13, 2012","journal-title":"N Engl J Med"},{"key":"6124_CR25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1056\/NEJMoa1615869","volume":"377","author":"TJ Wilt","year":"2017","unstructured":"Wilt TJ, Jones KM, Barry MJ, et al: Follow-up of Prostatectomy versus Observation for Early Prostate Cancer. N Engl J Med 377:132-142, 2017","journal-title":"N Engl J Med"},{"key":"6124_CR26","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1016\/S0140-6736(18)32486-3","volume":"392","author":"CC Parker","year":"2018","unstructured":"Parker CC, James ND, Brawley CD, et al: Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial. Lancet 392:2353-2366, 2018","journal-title":"Lancet"},{"key":"6124_CR27","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/annonc\/mdy072","volume":"29","author":"MR Sydes","year":"2018","unstructured":"Sydes MR, Spears MR, Mason MD, et al: Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol. Ann Oncol 29:1235-1248, 2018","journal-title":"Ann Oncol"},{"key":"6124_CR28","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1056\/NEJMoa1807801","volume":"379","author":"A Bill-Axelson","year":"2018","unstructured":"Bill-Axelson A, Holmberg L, Garmo H, et al: Radical Prostatectomy or Watchful Waiting in Prostate Cancer - 29-Year Follow-up. N Engl J Med 379:2319-2329, 2018","journal-title":"N Engl J Med"},{"key":"6124_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates D, Machler M, Bolker BM, et al: Fitting Linear Mixed-Effects Models Using lme4. J Stat Softw 67:1-48, 2015","journal-title":"J Stat Softw"},{"key":"6124_CR30","unstructured":"R Core Team R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2018. https:\/\/www.R-project.org\/"},{"key":"6124_CR31","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1136\/jech.2004.029454","volume":"60","author":"J Merlo","year":"2006","unstructured":"Merlo J, Chaix B, Ohlsson H, et al: A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health 60:290-7, 2006","journal-title":"J Epidemiol Community Health"},{"key":"6124_CR32","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1001\/jama.280.7.623","volume":"280","author":"HM Krumholz","year":"1998","unstructured":"Krumholz HM, Radford MJ, Wang Y, et al: National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA 280:623-9, 1998","journal-title":"JAMA"},{"key":"6124_CR33","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/BF02600301","volume":"9","author":"SH Sial","year":"1994","unstructured":"Sial SH, Malone M, Freeman JL, et al: Beta blocker use in the treatment of community hospital patients discharged after myocardial infarction. J Gen Intern Med 9:599-605, 1994","journal-title":"J Gen Intern Med"},{"key":"6124_CR34","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJM199410273311707","volume":"331","author":"JZ Ayanian","year":"1994","unstructured":"Ayanian JZ, Hauptman PJ, Guadagnoli E, et al: Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med 331:1136-42, 1994","journal-title":"N Engl J Med"},{"key":"6124_CR35","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S0140-6736(03)14546-1","volume":"362","author":"R Grol","year":"2003","unstructured":"Grol R, Grimshaw J: From best evidence to best practice: effective implementation of change in patients\u2019 care. Lancet 362:1225-1230, 2003","journal-title":"Lancet"},{"key":"6124_CR36","doi-asserted-by":"publisher","unstructured":"Fischer F, Lange K, Klose K, Greiner W, Kraemer A: Barriers and strategies in guideline Implementation-A Scoping Review. Healthcare (Basel)4(3):36, 2016. https:\/\/doi.org\/10.3390\/healthcare4030036.","DOI":"10.3390\/healthcare4030036"},{"key":"6124_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ijmedinf.2014.10.001","volume":"84","author":"D Dowding","year":"2015","unstructured":"Dowding D, Randell R, Gardner P, et al: Dashboards for improving patient care: review of the literature. Int J Med Inform 84:87-100, 2015","journal-title":"Int J Med Inform"},{"key":"6124_CR38","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s12913-019-4327-3","volume":"19","author":"PA Twohig","year":"2019","unstructured":"Twohig PA, Rivington JR, Gunzler D, et al: Clinician dashboard views and improvement in preventative health outcome measures: a retrospective analysis. BMC Health Serv Res 19:475, 2019","journal-title":"BMC Health Serv Res"},{"key":"6124_CR39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.amepre.2009.09.031","volume":"38","author":"RC Baron","year":"2010","unstructured":"Baron RC, Melillo S, Rimer BK, et al: Intervention to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers a systematic review of provider reminders. Am J Prev Med 38:110-7, 2010","journal-title":"Am J Prev Med"},{"key":"6124_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11606-018-4663-8","volume":"34","author":"T Jun","year":"2019","unstructured":"Jun T, Kwang H, Mou E, et al: An Electronic Best Practice Alert Based on Choosing Wisely Guidelines Reduces Thrombophilia Testing in the Outpatient Setting. J Gen Intern Med 34:29-30, 2019","journal-title":"J Gen Intern Med"},{"key":"6124_CR41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12911-017-0430-8","volume":"17","author":"JS Ancker","year":"2017","unstructured":"Ancker JS, Edwards A, Nosal S, et al: Effects of workload, work complexity, and repeated alerts on alert fatigue in a clinical decision support system. BMC Med Inform Decis Mak 17:36, 2017","journal-title":"BMC Med Inform Decis Mak"},{"key":"6124_CR42","doi-asserted-by":"publisher","unstructured":"Brown B, Young J, Smith DP, et al: A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial. Implement Sci 13(1):43, 2016. https:\/\/doi.org\/10.1186\/s13012-018-0733-x.","DOI":"10.1186\/s13012-018-0733-x"},{"key":"6124_CR43","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.eururo.2018.08.032","volume":"75","author":"MA Preston","year":"2019","unstructured":"Preston MA, Gerke T, Carlsson SV, et al: Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men. Eur Urol 75:399-407, 2019","journal-title":"Eur Urol"},{"key":"6124_CR44","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1007\/s11606-018-4633-1","volume":"33","author":"JM Guise","year":"2018","unstructured":"Guise JM, Savitz LA, Friedman CP: Mind the Gap: Putting Evidence into Practice in the Era of Learning Health Systems. J Gen Intern Med 33:2237-2239, 2018","journal-title":"J Gen Intern Med"},{"key":"6124_CR45","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12916-017-0935-0","volume":"15","author":"BI Nwaru","year":"2017","unstructured":"Nwaru BI, Friedman C, Halamka J, et al: Can learning health systems help organisations deliver personalised care? BMC Med 15:177, 2017","journal-title":"BMC Med"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-06124-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-020-06124-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-06124-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T01:21:38Z","timestamp":1630459298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-020-06124-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["6124"],"URL":"https:\/\/doi.org\/10.1007\/s11606-020-06124-2","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,1]]},"assertion":[{"value":"8 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was reviewed and deemed exempt\u00a0by the Duke Institutional Review Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Thomas J. Polascik reports consultancies in the last 3 years and honoraria in the last 3 years from Healthtronics [training agreement]. Terry Hyslop reports consultancies in the last 3 years from AbbVie. Glenn M. Preminger reports consultancies in the last 3 years from Boston Scientific, Auris Robotics, and Kalera Medical and reports other relationships as an Associate Editor for Up to Date. Kevin Shah reports stock ownership\/options other than mutual funds from Infinity Pharmaceuticals. Anand Shah reports stock ownership\/options other than mutual funds from Pfizer Inc.\u00a0All other authors report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}